BG9924 in Combination With Methotrexate Extension of Study 104RA203 (NCT 00458861)

Stopped early · Phase 2

Conditions studied: Rheumatoid Arthritis

In brief

This study is to observe the long-term treatment of BG9924

Key facts

Study ID

NCT00523328

Run by

Biogen

People needed

72

Starts

2007-08-01

Expected to finish

2008-10-01

Last updated by the study team

2016-01-21

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Must be a participant from Study 104RA203 (NCT 00458861)

You may not qualify if…

• Participants with a significant change in medical history from their previous BG9924 Study 104RA203 (NCT 00458861).
• Nursing mothers, pregnant women, or women who are planning to become pregnant while in the study.
• Male and female participants of child-bearing potential not willing to practice effective birth control for the duration of the study.
• NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.

Where it is running

• Coordinating Research Site — Palo Alto, California, United States
• Coordinating Research Site — Liège, Belgium
• Coordinating Research Site — Toronto, Ontario, Canada
• Coordinating Research Site — Newcastle, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.